Diagnos Laboratorium Utama Tbk. vs Enseval Putera Megatrading Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Enseval Putera Megatrading Tbk. trades at Rp2,330 (market cap 6.23T, 3.1K 24h volume). The key difference: Enseval Putera Megatrading Tbk. is far larger — about 20× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (963.6K versus 3.1K). Which is the better fit depends on your goals.
| DGNS | EPMT | |
|---|---|---|
Market Cap | 310.75B | 6.23T |
Volume | 963.6K | 3.1K |
Lot | 9.64K | 31 |
Turnover | 217.67M | 7.21M |
Average Price | 225.89 | 2,325.48 |
Value | 217.67M | 7.21M |
Indicative Equilibrium Price | 226 | — |
Indicative Equilibrium Volume | 1K | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT. Enseval Putera Megatrading Tbk, formerly PT Arya Gupta Cempaka, was established based on deed No. 64 dated October 26, 1998 of Mrs. Rukmasanti Hardjasatya,SH, notary public in Jakarta. The company’s articles of association have been amended several times, most recently by deed No. 200 dated June 30, 1997 of Mrs. Poerbaningsih Adi Warsito, SH, notary public in Jakarta, concerning the changes of the company’s articles of association to comply with Corporate Law no. 1 year 1995, the increase in the company’s authorized capital and the change in par value per share from Rp 1,000 to Rp 500.
Read more on EPMT →